<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03086408</url>
  </required_header>
  <id_info>
    <org_study_id>40295</org_study_id>
    <nct_id>NCT03086408</nct_id>
  </id_info>
  <brief_title>Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Diagnostic Bronchoscopy</brief_title>
  <official_title>The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Short Diagnostic Bronchoscopy Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether diagnostic bronchoscopy can be safely and
      potentially more effectively performed without the use of tracheal intubation or a
      supraglottic airway, under completely unobstructed surgical conditions afforded by THRIVE:
      Transnasal Humidified Rapid- Insufflation Ventilatory Exchange. THRIVE provides patient's gas
      exchange through rapid insufflation of high-flow oxygen via specialized nasal cannula.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 9, 2017</start_date>
  <completion_date type="Actual">June 10, 2019</completion_date>
  <primary_completion_date type="Actual">June 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lowest Intraoperative Peripheral Oxygen Saturation (SpO2)</measure>
    <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
    <description>Peripheral oxygen saturation is an estimate of the amount of oxygen in the blood.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Awakening/Extubation Time</measure>
    <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
    <description>Recorded from the end of surgery until the return of patient's protective airway reflexes and patient opening eyes to command.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Bronchoscope Placement in Trachea</measure>
    <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
    <description>Recorded from the moment of the introduction of the bronchoscope in patient's mouth to tracheal placement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Tracheal Bronchoscope Placements Required</measure>
    <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of Procedure</measure>
    <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
    <description>Recorded from the introduction of the bronchoscope in patient's mouth to withdrawing the bronchoscope at the completion of procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Patient Being Alert and Oriented x 4</measure>
    <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
    <description>Recorded from patient's admission to the post-anesthesia care unit (PACU) to patient's orientation to person, place, time, and situation as assessed by the recovery room nurse.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery Room Discharge-ready Time</measure>
    <time_frame>Duration of recovery room stay (average approximately 1 hour)</time_frame>
    <description>From admission to recovery room, to discharge from recovery room</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Pain Score in Recovery Room</measure>
    <time_frame>Duration of recovery room stay (average approximately 1 hour)</time_frame>
    <description>Pain was measured using an 11-point visual analogue scale (VAS). Range: 0-11 (0 = no pain; 11 = worst pain imaginable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge-ready Pain Score</measure>
    <time_frame>Day of discharge (up to 2 minutes)</time_frame>
    <description>Pain was measured using an 11-point visual analogue scale (VAS). Range: 0-11 (0 = no pain; 11 = worst pain imaginable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic Consumption</measure>
    <time_frame>Recovery room to 7th postoperative day</time_frame>
    <description>Analgesic consumption was measured in oral morphine milligram equivalents (MME)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Bronchoscopy</condition>
  <arm_group>
    <arm_group_label>THRIVE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high flow nasal oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>endotracheal tube or supraglottic airway</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tracheal intubation or supraglottic airway device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THRIVE</intervention_name>
    <description>active nasal oxygen delivery system</description>
    <arm_group_label>THRIVE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endotracheal tube or Supraglottic airway</intervention_name>
    <description>Plastic devices for mechanical ventilation</description>
    <arm_group_label>endotracheal tube or supraglottic airway</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting for diagnostic bronchoscopy

        Exclusion Criteria:

          -  Patients with significantly decreased myocardial function (ejection fraction &lt; 50%)

          -  Patients with abnormal cardiac rhythm and conduction abnormalities, except for
             patients with isolated, asymptomatic premature atrial and ventricular contractions.

          -  Patients with significant peripheral vascular disease, such as those with the symptoms
             of intermittent claudication.

          -  Patients with known significant cerebrovascular disease, such as history of
             cerebrovascular accidents (CVAs) and transient ischemic attacks (TIAs).

          -  Patients with significant renal insufficiency, as manifested by estimated glomerular
             filtration rate (eGFR) &lt; 60 ml/min/1.73 m2.

          -  Patients with electrolyte (K+, Ca++) abnormalities, as determined by the lab values
             outside of a normal range.

          -  Patients with the history or symptoms of increased intracranial pressure or reduced
             intracranial compliance (e.g. headaches, nausea and vomiting, visual changes, mental
             changes).

          -  Patients with skull base defects.

          -  Patients with pulmonary hypertension who have pulmonary artery pressures above the
             normal range.

          -  Patients with significant chronic obstructive or restrictive lung diseases, as
             manifested by known history of baseline chronic hypoxia and/or hypercapnia, and/or
             baseline room air SpO2 &lt; 95%.

          -  Obese patients with BMI above 35 kg/m2.

          -  Patients with severe and poorly controlled gastroesophageal reflux disease despite
             medical treatment.

          -  Patients with hiatal hernia and full stomach patients.

          -  Patients on immunosuppressive medications.

          -  Patient's refusal to participate in the study.

          -  Patients who do not understand English or mentally handicapped.

          -  Pregnant or breastfeeding patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir Nekhendzy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford Hospital and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 6, 2017</study_first_submitted>
  <study_first_submitted_qc>March 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <results_first_submitted>June 10, 2020</results_first_submitted>
  <results_first_submitted_qc>June 10, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 23, 2020</results_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Vladimir Nekhendzy</investigator_full_name>
    <investigator_title>Clinical Professor of Anesthesiology and Otolaryngology</investigator_title>
  </responsible_party>
  <keyword>airway management</keyword>
  <keyword>high flow nasal oxygen</keyword>
  <keyword>high flow nasal cannula</keyword>
  <keyword>THRIVE</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 21, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/08/NCT03086408/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 9, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/08/NCT03086408/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>THRIVE</title>
          <description>Participants receive Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) active nasal oxygen delivery system.</description>
        </group>
        <group group_id="P2">
          <title>Endotracheal Tube or Supraglottic Airway</title>
          <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>THRIVE</title>
          <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
        </group>
        <group group_id="B2">
          <title>Endotracheal Tube or Supraglottic Airway</title>
          <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.5" spread="19.01"/>
                    <measurement group_id="B2" value="56.5" spread="16.17"/>
                    <measurement group_id="B3" value="55.0" spread="17.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Lowest Intraoperative Peripheral Oxygen Saturation (SpO2)</title>
        <description>Peripheral oxygen saturation is an estimate of the amount of oxygen in the blood.</description>
        <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Lowest Intraoperative Peripheral Oxygen Saturation (SpO2)</title>
          <description>Peripheral oxygen saturation is an estimate of the amount of oxygen in the blood.</description>
          <units>percentage of oxygen</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.7" spread="6.65"/>
                    <measurement group_id="O2" value="98.7" spread="1.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.09</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.00</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Awakening/Extubation Time</title>
        <description>Recorded from the end of surgery until the return of patient's protective airway reflexes and patient opening eyes to command.</description>
        <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Awakening/Extubation Time</title>
          <description>Recorded from the end of surgery until the return of patient's protective airway reflexes and patient opening eyes to command.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1" spread="2.42"/>
                    <measurement group_id="O2" value="9.2" spread="4.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.61</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.89</ci_lower_limit>
            <ci_upper_limit>4.69</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to Bronchoscope Placement in Trachea</title>
        <description>Recorded from the moment of the introduction of the bronchoscope in patient's mouth to tracheal placement.</description>
        <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Bronchoscope Placement in Trachea</title>
          <description>Recorded from the moment of the introduction of the bronchoscope in patient's mouth to tracheal placement.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="0.38"/>
                    <measurement group_id="O2" value="1.1" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.78</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.07</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.61</ci_lower_limit>
            <ci_upper_limit>0.47</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Tracheal Bronchoscope Placements Required</title>
        <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Tracheal Bronchoscope Placements Required</title>
          <units>placements</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.42"/>
                    <measurement group_id="O2" value="0.6" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.30</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.30</ci_lower_limit>
            <ci_upper_limit>0.50</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Duration of Procedure</title>
        <description>Recorded from the introduction of the bronchoscope in patient's mouth to withdrawing the bronchoscope at the completion of procedure.</description>
        <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Procedure</title>
          <description>Recorded from the introduction of the bronchoscope in patient's mouth to withdrawing the bronchoscope at the completion of procedure.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6" spread="7.90"/>
                    <measurement group_id="O2" value="15.5" spread="11.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.98</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.62</ci_lower_limit>
            <ci_upper_limit>8.82</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Patient Being Alert and Oriented x 4</title>
        <description>Recorded from patient's admission to the post-anesthesia care unit (PACU) to patient's orientation to person, place, time, and situation as assessed by the recovery room nurse.</description>
        <time_frame>Duration of surgery (average approximately 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Patient Being Alert and Oriented x 4</title>
          <description>Recorded from patient's admission to the post-anesthesia care unit (PACU) to patient's orientation to person, place, time, and situation as assessed by the recovery room nurse.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="3.12"/>
                    <measurement group_id="O2" value="0.67" spread="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.61</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.64</ci_lower_limit>
            <ci_upper_limit>2.84</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recovery Room Discharge-ready Time</title>
        <description>From admission to recovery room, to discharge from recovery room</description>
        <time_frame>Duration of recovery room stay (average approximately 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Recovery Room Discharge-ready Time</title>
          <description>From admission to recovery room, to discharge from recovery room</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.3" spread="17.09"/>
                    <measurement group_id="O2" value="16.6" spread="8.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>13.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.63</ci_lower_limit>
            <ci_upper_limit>26.77</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Pain Score in Recovery Room</title>
        <description>Pain was measured using an 11-point visual analogue scale (VAS). Range: 0-11 (0 = no pain; 11 = worst pain imaginable).</description>
        <time_frame>Duration of recovery room stay (average approximately 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>First Pain Score in Recovery Room</title>
          <description>Pain was measured using an 11-point visual analogue scale (VAS). Range: 0-11 (0 = no pain; 11 = worst pain imaginable).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="2.41"/>
                    <measurement group_id="O2" value="1.3" spread="2.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>1</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.80</ci_lower_limit>
            <ci_upper_limit>2.80</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Discharge-ready Pain Score</title>
        <description>Pain was measured using an 11-point visual analogue scale (VAS). Range: 0-11 (0 = no pain; 11 = worst pain imaginable).</description>
        <time_frame>Day of discharge (up to 2 minutes)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Discharge-ready Pain Score</title>
          <description>Pain was measured using an 11-point visual analogue scale (VAS). Range: 0-11 (0 = no pain; 11 = worst pain imaginable).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="1.66"/>
                    <measurement group_id="O2" value="1.3" spread="2.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.82</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.38</ci_lower_limit>
            <ci_upper_limit>1.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analgesic Consumption</title>
        <description>Analgesic consumption was measured in oral morphine milligram equivalents (MME)</description>
        <time_frame>Recovery room to 7th postoperative day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>THRIVE</title>
            <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
          </group>
          <group group_id="O2">
            <title>Endotracheal Tube or Supraglottic Airway</title>
            <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Analgesic Consumption</title>
          <description>Analgesic consumption was measured in oral morphine milligram equivalents (MME)</description>
          <units>MME</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="1.58"/>
                    <measurement group_id="O2" value="2" spread="4.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.37</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.29</ci_lower_limit>
            <ci_upper_limit>2.29</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 1 week</time_frame>
      <group_list>
        <group group_id="E1">
          <title>THRIVE</title>
          <description>Participants receive THRIVE active nasal oxygen delivery system.</description>
        </group>
        <group group_id="E2">
          <title>Endotracheal Tube or Supraglottic Airway</title>
          <description>Participants receive tracheal intubation or supraglottic airway device for mechanical ventilation.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Vladimir Nekhendzy, M.D., FASA</name_or_title>
      <organization>Stanford University</organization>
      <phone>650-498-4055</phone>
      <email>nek@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

